Bone Sarcoma
Clinical research at Istituto Ortopedico Rizzoli includes treatment strategies for bone sarcoma, with attention to osteosarcoma and Ewing’s sarcoma. The sponsor’s activity is centered on disease control in patients with a high risk of relapse and on outcomes relevant to long-term oncologic management.
- Osteosarcoma
- Ewing’s sarcoma
- Relapse risk
- Event-free survival
These studies reflect an interest in improving survival-related endpoints in aggressive skeletal malignancies treated within an orthopedic oncology setting.
Osteogenesis Imperfecta
The sponsor also investigates osteogenesis imperfecta, focusing on care for older adolescents and adults with this inherited bone fragility disorder. Research activity in this area addresses skeletal health, bone turnover, and treatment responsiveness in a population with ongoing fracture vulnerability.
- Bone fragility
- Adolescent and adult care
- Bone turnover markers
- Skeletal disease management
Work in this field aligns with clinical interest in inherited disorders of connective tissue and their orthopedic consequences.
Orthopedic Oncology
Istituto Ortopedico Rizzoli maintains a research profile in orthopedic oncology, linking tumor care with musculoskeletal expertise. The funded studies involve malignancies arising in bone and support clinical attention to disease behavior, relapse prevention, and patient outcomes in specialized orthopedic practice.
- Musculoskeletal tumors
- Specialist bone cancer care
- High-risk disease
- Oncologic follow-up
This area reflects the institution’s focus on conditions where surgical, structural, and oncologic considerations overlap.
Bone Metabolism
Another clear theme is bone metabolism, particularly the measurement of biochemical markers linked to bone resorption in osteogenesis imperfecta. The research interest extends to understanding skeletal remodeling and its role in guiding treatment decisions for disorders with altered bone strength.
- Bone resorption
- Biochemical markers
- Skeletal remodeling
- Collagen turnover
These topics place emphasis on measurable biological features of bone disease relevant to clinical management.
